Brief: Reviva Reports Full Year 2025 Financial Results And Recent Business Highlights
30/03/2026 14:57
March 30 (Reuters) - Reviva Pharmaceuticals Holdings Inc RVPH.O: REVIVA REPORTS FULL YEAR 2025 FINANCIAL RESULTS AND RECENT BUSINESS HIGHLIGHTS REVIVA PHARMACEUTICALS FY NET INCOME USD -19.9 MILLION REVIVA PHARMACEUTICALS FY EPS USD -5.48 Source text: ID:nGNXGrsyb Further company coverage: RVPH.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Reviva Pharmaceuticals Holdings
See all newsReviva Pharmaceuticals Q1 net loss narrows on lower expenses
Brief: Reviva Pharmaceuticals Holdings Inc - To Be Delisted From Nasdaq Trading Suspended As Of May 14, 2026 - SEC Filing
Brief: Reviva Reports Full Year 2025 Financial Results And Recent Business Highlights
Reviva Pharmaceuticals' 2025 net loss narrows on lower R&D spending
U.S. STOCKS ON THE MOVE-Darden Restaurants, Mastercard, Accenture